Melanoma Follow Up R3767-ONC-2466
TEMPORARILY CLOSED TO ENROLLMENT
This study is researching the long-term effects of a combination of experimental drugs called fianlimab and cemiplimab. The study is being conducted in patients with advanced skin cancer (melanoma) who had previously been treated with fianlimab and cemiplimab in the study called R3767-ONC-1613 (NCT03005782).
Research topics
Related studies
View all studies- Research study
Melanoma DECIDE
DecisionDx-Melanoma Impact in Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes
- Research study
Bone Marrow Transplant Database
Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
- Research study
Cancer Liquid Biopsy Monitoring Study
A study testing the clinical utility of liquid biopsy for monitoring Sutter patients treated for metastatic melanoma or lung cancer.
- Research study
Adjuvant Advanced Cervical Cancer GY037
A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer
- Research study
Ductal Carcinoma In Situ (DCIS) Registry Dana Farber
Molecular Characterization of Breast Cancer with Duct Forming Features